Top Japanese Pharmas Show Appetite For Emerging Market Expansion, Will Generics Follow?
This article was originally published in PharmAsia News
TOKYO - Japanese pharma companies are trying to determine how to expand into new markets, ranging from the U.S. to China, and IMS Health data show a slow move away from dependence on the domestic market for Japan's leading companies
You may also be interested in...
The European pharma trade group also plans communication offensive on health technology assessment as Japan reconsiders pricing methodology.
Japanese pharma appetite for licensing deals exploded in 2011, as did appetite for foreign marketing rights.
Japanese pharma’s appetite for licensing deals exploded in 2011, as did its appetite for foreign marketing rights.